Want to track DHR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 54 days
Danaher (DHR) Gears Up to Post Q2 Earnings: What to Expect
Danaher's (DHR) second-quarter earnings are likely to be aided by strength in the Diagnostics and Life Sciences segment.
Zacks | 1 year ago
Danaher (DHR) Upgraded to Buy: Here's What You Should Know
Danaher (DHR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks | 1 year ago
Is Danaher (DHR) Stock Outpacing Its Conglomerates Peers This Year?
Here is how Danaher (DHR) and Honeywell International Inc. (HON) have performed compared to their sector so far this year.
Zacks | 1 year ago
Here's Why Hold Strategy Is Apt for Danaher (DHR) Stock Now
Strength in the Life Sciences segment augurs well for Danaher (DHR). The company's measures to reward its shareholders are promising.
Zacks | 1 year ago
Why Is Danaher (DHR) Up 6.7% Since Last Earnings Report?
Danaher (DHR) reported earnings 30 days ago. What's next for the stock?
Zacks | 1 year ago
2025 © Marketlog. All Rights Reserved.
